WHO says Mpox is an Ongoing health emergency
On Jun. 9, 2025, the World Health Organization (WHO) said the mpox outbreak is still a public health…
Genomic data shows widespread mpox transmission in West Africa prior to 2022 global outbreak
On May 19, 2025, Scripps scientists, in collaboration with researchers in Nigeria and Cameroon, announced genomic data has…
New York State Department of Health Issued Health Advisory on First Mpox Clade Ib Case Detected in New York
On Feb. 12, 2025, the New York State Department of Health issued a Health Advisory to health care…
SIGA technologies’ TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
On Jan. 2, 2025, SIGA Technologies announced that its antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as…
Africa CDC Deployed Experts to Investigate unknown Disease X outbreak in Democratic Republic of Congo
On Dec. 9, 2024, the Africa Centers for Disease Control (CDC) announced that it is working closely with…
Biotechnology | COVID-19 | HIV | Vaccine
mpox confirmed in two more nations
On Dec. 5, 2024, the World Health Organization (WHO) announced that as of December 1, 20 countries have…
Health officials investigated mystery disease in southwest Congo after 143 deaths
On Dec. 3, 2024, Congolese officials reported that a flu-like disease that has killed dozens of people over…
Public Health Agency of Canada confirmed first case of clade I mpox in Canada
On Nov. 22, 2024, the Public Health Agency of Canada (PHAC) confirmed the first case of clade I…
Biotechnology | COVID-19 | HIV | Vaccine
WHO added LC16m8 mpox vaccine to Emergency Use Listing
On Nov. 19, 2024, the World Health Organization (WHO) announced it had granted Emergency Use Listing (EUL) to Japan-based…
California Reported First Known U.S. Case of Emerging Mpox Strain
On Nov. 16, 2024, the California Department of Public Health (CDPH) announced it had identified through laboratory testing…
Vaccine doses allocated to African countries hardest hit by mpox surge
On Nov. 9, 2024, the World Health Organization announced that three additional countries had confirmed travel-related cases of…
Vaccine doses allocated to African countries hardest hit by mpox surge
On Nov. 6, 2024, the World Health Organization announced that the Access and Allocation Mechanism (AAM) for mpox…
WHO and partners activated Global Health Emergency Corps for the first time in response to mpox outbreak
On Oct. 29, 2024, the World Health Organization (WHO) announced that it had, in collaboration with Member States,…
Mpox vaccine is safe and generates a robust antibody response in adolescents
On Oct. 16, 2024, a National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents…
New risks raise pandemic threat on a global scale
On Oct. 14, 2024, the Global Preparedness Monitoring Board (GPMB) released a report that outlined 15 key drivers…
U.S. officials reported Cluster of drug-resistant mpox identified in five states
On Oct. 10, 2024, health officials from the U.S. Centers for Disease Control and Prevention announced they had…
WHO approved first mpox diagnostic test for emergency use, boosting global access
On Oct. 3, 2024, the World Health Organization (WHO) announced it had listed the first mpox in vitro…
White House announced 1 million vaccine doses for Africa’s mpox response
On Sept. 24, 2024, U.S. President Joe Biden announced the donation of 1 million mpox vaccine doses and…
EMA recommended extending indication of mpox vaccine to adolescents
On Sept. 19, 2024, the European Medical Agency (EMA) announced it had recommended extending the indication of the…
Emergent BioSolutions’ ACAM2000® Received U.S. FDA Approval for Mpox Indication
On Aug. 29, 2024, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
scientist-run Pathoplexus virus database vows to be transparently run and simple to use
On Aug. 29, 2024, a small team of scientists has launched an open-source database for some of the…
Vaccine Misinformation caused U.S. Covid-19 Vaccination rate to Drop
On Aug. 28, 2024, survey data from the Annenberg Public Policy Center (APPC) found that the number of…
Biotechnology | Disease | Therapeutics | Vaccine | WHO
Global strategic preparedness and response plan launched by WHO to contain mpox outbreak
On Aug. 26, 2024, the World Health Organization (WHO) launched a global Strategic Preparedness and Response Plan to…
ECDC recommended enhancing preparedness as more imported cases of clade I mpox highly likely
ON Aug. 16, 2024, the European Centre for Disease Prevention and Control (ECDC) reported that it is highly…
Biotechnology | Disease | Medicine | Vaccine | WHO
WHO declared mpox outbreak a public health emergency of international concern
On Aug. 14, 2024, The World Health Organization declared that the upsurge of mpox in the Democratic Republic…
Labcorp received FDA Emergency Use Authorization for Mpox PCR test home collection kit
On Apr. 10, 2024, LabCorp announced announced that the U.S. Food and Drug Administration (FDA) had granted Emergency…
Bavarian Nordicﾒs Mpox vaccine received recommendation from U.S. CDC Advisory Committee for routine use in adults at risk
On Oct. 25, 2023, Bavarian Nordic announced that the U.S. Centers for Disease Control and Preventionﾒs (CDC) Advisory…
WHO declared end to mpox public health emergency
On May 10, 2023, the World Health Organization announced it was ending a 10-month-long global health emergency for…
NIH scientists develop mouse model to study Mpox virulence
On Feb. 14, 2023, scientists from the National Institute of Allergy and Infectious Diseases announced they had developed…
FDA authorized first Mpox test
On Feb. 10, 2023, the U.S. Food and Drug Administration issued an emergency use authorization for the first…